Showing results (21-30 of 3,279) with videos related to
Sort By:
Pageof 328
Metabolic Brain Disease|November 21, 2022
Baseline severity and soluble vascular cell adhesion molecule 1 (sVCAM-1) as biomarker predictors of short-term mortality in acute ischemic strokeMaria Caroline Martins de Araújo, Daniela Frizon Alfieri, Ana Lucia Cruz Fürstenberger Lehmann, et al.Metabolic Brain Disease|January 18, 2023
Network pharmacology and bioinformatics approach reveals the therapeutic mechanism of action of curcumin in Alzheimer diseaseDeepanshi Vijh, Md Ali Imam, Mohd Maksuf Ul Haque, et al.Metabolic Brain Disease|January 4, 2023
Oxidative stress: a common imbalance in diabetes and epilepsyKaren Paola Ramos-Riera, Francisca Pérez-Severiano, María Leonor López-MerazMetabolic Brain Disease|December 21, 2022
D-beta-hydroxybutyrate protects against microglial activation in lipopolysaccharide-treated mice and BV-2 cellsYuping Zhang, Kun Liu, Yunpeng Li, et al.Metabolic Brain Disease|June 7, 2022
Rapamycin ameliorates brain damage and maintains mitochondrial dynamic balance in diabetic rats subjected to middle cerebral artery occlusionChangchun Hei, Yujia Zhou, Chenyang Zhang, et al.Metabolic Brain Disease|December 1, 2022
8-O-acetyl shanzhiside methylester protects against sleep deprivation-induced cognitive deficits and anxiety-like behaviors by regulating NLRP3 and Nrf2 pathways in miceYu-Jiao Li, Xiao-Lu He, Jie-Yu Zhang, et al.Metabolic Brain Disease|December 5, 2022
H2S-mediated inhibition of RhoA/ROCK pathway and noncoding RNAs in ischemic strokeWeizhuo Lu, Jiyue WenMetabolic Brain Disease|November 27, 2022
The curative and mechanistic acumen of curcuminoids formulations against haloperidol induced Parkinson's disease animal modelUzma Saleem, Sundas Khalid, Zunera Chauhdary, et al.Metabolic Brain Disease|November 29, 2022
Celastrol assuages oxygen-glucose deprivation and reoxygenation-induced damage in human brain microvascular endothelial cells through the circDLGAP4/miR-6085/GDF11 pathwayChunhong Liu, Jiahui Gu, Yingli YuMetabolic Brain Disease|November 29, 2022
Evidence of redox imbalance and mitochondrial dysfunction in Niemann-Pick type C 1 patients: the in vitro effect of combined therapy with antioxidants and β-cyclodextrin nanoparticlesTatiane Grazieli Hammerschmidt, Bruna Donida, Marco Raabe, et al.Pageof 328